{"id":347258,"date":"2026-11-14T20:02:44","date_gmt":"2026-11-14T14:32:44","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/aarey-drugs-and-pharmaceuticals-q2-results-fy27-pat-1-crore\/"},"modified":"2026-11-14T20:02:44","modified_gmt":"2026-11-14T14:32:44","slug":"aarey-drugs-and-pharmaceuticals-q2-results-fy27-pat-1-crore","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/aarey-drugs-and-pharmaceuticals-q2-results-fy27-pat-1-crore\/","title":{"rendered":"Aarey Drugs & Pharmaceuticals Q2 Results FY27: Revenue Up 5.3% to Rs 88.62 Cr, PAT Rs 1.37 Cr"},"content":{"rendered":"
\n

Quick Answer<\/strong><\/p>\n

Aarey Drugs & Pharmaceuticals Q2 Results FY27 were declared on 14 November 2026 on a Standalone basis, with revenue of Rs 88.62 Cr, up 5.3% YoY from Rs 84.16 Cr. Net profit came in at Rs 1.37 Cr, up 34.31% YoY from Rs 1.02 Cr. These quarterly results show positive YoY growth in revenue and net profit, and negative YoY growth in Operating Profit. The Financial Highlights table below gives the full comparison.<\/p>\n<\/div>\n

Aarey Drugs & Pharmaceuticals Ltd<\/a> (AAREYDRUGS) Q2 Results FY27 announced on 14 November 2026, covering the company’s financial performance for the July to September quarter. Revenue stood at Rs 88.62 Cr and PAT at Rs 1.37 Cr, which are the headline figures of Aarey Drugs & Pharmaceuticals Q2 Results FY27 for readers following the results date. These are standalone results, and every figure below is on that Standalone basis.<\/p>\n

This Aarey Drugs & Pharmaceuticals Q2 Results analysis covers the financial highlights, the business drivers, the outlook and the risks. The results analysis begins with the Financial Highlights table, which sets this quarter against the same quarter last year, and then works through each section in the order a reader would ask about it.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n